These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 16953203

  • 1. Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis.
    Mori T, Aisa Y, Yamazaki R, Mihara A, Ikeda Y, Okamoto S.
    Bone Marrow Transplant; 2006 Nov; 38(9):637-8. PubMed ID: 16953203
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
    Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S.
    J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of high-dose melphalan-induced mucositis by cryotherapy.
    Tartarone A, Matera R, Romano G, Vigliotti ML, Di Renzo N.
    Leuk Lymphoma; 2005 Apr; 46(4):633-4. PubMed ID: 16019498
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy Trial.
    Cho YK, Sborov DW, Lamprecht M, Li J, Wang J, Hade EM, Gao Y, Tackett K, Williams N, Benson DM, Efebera YA, Rosko AE, Devine SM, Poi M, Hofmeister CC, Phelps MA.
    Clin Pharmacol Ther; 2017 Sep; 102(3):511-519. PubMed ID: 28160288
    [Abstract] [Full Text] [Related]

  • 9. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
    McCann S, Schwenkglenks M, Bacon P, Einsele H, D'Addio A, Maertens J, Niederwieser D, Rabitsch W, Roosaar A, Ruutu T, Schouten H, Stone R, Vorkurka S, Quinn B, Blijlevens N, EBMT Mucositis Advisory Group.
    Bone Marrow Transplant; 2009 Jan; 43(2):141-7. PubMed ID: 18776926
    [Abstract] [Full Text] [Related]

  • 10. Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.
    Thieblemont C, Dumontet C, Saad H, Roch N, Bouafia F, Arnaud P, Hequet O, Espinouse D, Salles G, Roy P, Eljaafari-Corbin A, Du Manoir-Baumgarten C, Coiffier B.
    Bone Marrow Transplant; 2002 Dec; 30(11):769-75. PubMed ID: 12439700
    [Abstract] [Full Text] [Related]

  • 11. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
    Chen J, Seabrook J, Fulford A, Rajakumar I.
    J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
    [Abstract] [Full Text] [Related]

  • 12. Use of sidestream dark-field (SDF) imaging for assessing the effects of high-dose melphalan and autologous stem cell transplantation on oral mucosal microcirculation in myeloma patients.
    Milstein DM, te Boome LC, Cheung YW, Lindeboom JA, van den Akker HP, Biemond BJ, Ince C.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jan; 109(1):91-7. PubMed ID: 20123381
    [Abstract] [Full Text] [Related]

  • 13. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model.
    Grazziutti ML, Dong L, Miceli MH, Krishna SG, Kiwan E, Syed N, Fassas A, van Rhee F, Klaus H, Barlogie B, Anaissie EJ.
    Bone Marrow Transplant; 2006 Oct; 38(7):501-6. PubMed ID: 16980998
    [Abstract] [Full Text] [Related]

  • 14. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
    Batlle M, Morgades M, Vives S, Ferrà C, Oriol A, Sancho JM, Xicoy B, Moreno M, Magallón L, Ribera JM.
    Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
    [Abstract] [Full Text] [Related]

  • 15. Stem-cell collection before high-dose therapy for multiple myeloma: time has come to raise the standards!
    Mohty M.
    Leukemia; 2009 Oct; 23(10):1689-90. PubMed ID: 19826430
    [No Abstract] [Full Text] [Related]

  • 16. [Autologous stem cell transplantation in multiple myeloma - pro].
    Goldschmidt H.
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1942. PubMed ID: 19760555
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan-induced oral mucositis during hematological stem-cell transplantation: a prospective clinical study.
    de Paula Eduardo F, Bezinelli LM, da Graça Lopes RM, Nascimento Sobrinho JJ, Hamerschlak N, Correa L.
    Hematol Oncol; 2015 Sep; 33(3):152-8. PubMed ID: 24519448
    [Abstract] [Full Text] [Related]

  • 19. High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later.
    Lazarus HM, Phillips GL, Herzig RH, Hurd DD, Wolff SN, Herzig GP.
    J Clin Oncol; 2008 May 10; 26(14):2240-3. PubMed ID: 18467711
    [No Abstract] [Full Text] [Related]

  • 20. Stem cell mobilization in heavily pretreated multiple myeloma patients with prior high dose melphalan and auto-SCT.
    Khaled Y, Al-Hazzouri A, Mizrachi A, Reynolds R, Reddy V, Solh M.
    Bone Marrow Transplant; 2013 Feb 10; 48(2):310-1. PubMed ID: 22773127
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.